Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
06/2012
06/27/2012EP1692187B1 EC SOD and cell transducing EC SOD and use thereof
06/27/2012CN102517319A Method for purifying fusion protein based on bombyx mori baculovirus polyhedron dissolving characteristic
06/27/2012CN102516399A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
06/27/2012CN102516398A Method for constructing anti-mammitis transgenic mouse model and special vector for method
06/27/2012CN102516397A Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine
06/27/2012CN102516396A Induced reversible immortalized anterior odontoblast system and establishment method thereof
06/27/2012CN102516395A Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
06/27/2012CN102516394A CMG 2mutant and Fc fusion protein, its encoding gene and its application
06/27/2012CN102516393A Insulin mimetic peptide fusion protein, mutant and applications thereof
06/27/2012CN102516392A Cancer-targeted super antigen fusion protein, and preparation method and application thereof
06/27/2012CN102516372A A mutated immunoglobulin-binding protein
06/27/2012CN102516371A a mutated immunoglobulin-binding protein
06/27/2012CN102512674A Fish broad-spectrum vibrio subunit vaccine and preparation method
06/27/2012CN101928718B Protein trimerization modif and application thereof
06/27/2012CN101906163B Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
06/27/2012CN101684160B Recombinant protein for diagnosing bovine tuberculosis and application thereof
06/27/2012CN101481421B Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene
06/27/2012CN101460623B Novel anti-CD98 antibody
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2605629C Nipah virus vaccines
06/26/2012CA2452716C Mammalian sweet and amino acid heterodimeric taste receptors
06/21/2012WO2012040323A3 Multimeric il-15 soluble fusion molecules and methods of making and using same
06/21/2012WO2012021512A3 Erythrocyte-binding therapeutics
06/21/2012US20120157393 Biopolymer, implant comprising it and uses thereof
06/21/2012US20120156237 Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
06/21/2012US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2464663A2 Engineered proteins including mutant fibronectin domains
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP1534738B1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
06/20/2012EP1463942B2 Methods for purifying protein
06/20/2012CN101967194B Recombinant human cell restin MHD fusion protein and preparation method thereof
06/20/2012CN101870734B Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
06/20/2012CN101643501B Novel antibiotic and nucleotide sequence, preparation method and application thereof
06/20/2012CN101072793B Il-7 variants with reduced immunogenicity
06/19/2012US8202966 Human Dickkopf-related protein and nucleic acid molecules and uses therefor
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012CA2474108C Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/14/2012WO2012078906A2 Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
06/14/2012WO2012078816A2 Proteins that efficiently generate singlet oxygen
06/14/2012WO2012078741A2 Novel fungal esterases
06/14/2012WO2012077849A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells
06/14/2012WO2012077080A1 Compositions for separation methods
06/14/2012WO2012050714A3 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof
06/14/2012US20120149880 Nucleic Acid Cassette For Producing Recombinant Antibodies
06/14/2012US20120149875 Affinity chromatography matrix
06/14/2012US20120149870 Sequentially arranged streptavidin-binding modules as affinity tags
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149097 Nonviral vectors for delivering polynucleotides to target tissue
06/14/2012US20120149085 Fusion proteins containing recombinant cytotoxic rnases
06/14/2012US20120149053 Carrier peptide fragment and use thereof
06/14/2012US20120148628 Compositions and methods for treatment of cancer
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148585 Fusion molecules and methods for treatment of immune diseases
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148526 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012US20120148499 Peptides and aptamers for targeting of neuron or nerves
06/14/2012CA2820861A1 Compositions for separation methods
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820630A1 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/13/2012EP2463302A1 Multivalent immunoglobulins modified in the structural loop region
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN102492043A Anti-tumor and thrombolytic dual-effect chimeric protein with low immunogenicity, its preparation method and application
06/13/2012CN102492042A 3F3Rmg recombinant fusion protein and preparation method thereof and application thereof to detection of dog rabies antibody
06/13/2012CN102492041A HIV (Human Immunodeficiency Virus) recombinant fusion antigen as well as expression gene and preparation method thereof
06/13/2012CN101875699B Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof
06/13/2012CN101817883B Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof
06/13/2012CN101654679B Anti-tumor fusion gene and expression protein and application thereof
06/13/2012CN101607983B Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications
06/12/2012US8198404 Mutated immunoglobulin-binding protein
06/12/2012CA2502385C Il-1 receptor based antagonists and methods of making and using
06/12/2012CA2288992C Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/07/2012WO2012074330A2 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
06/07/2012WO2012071649A1 Covalently dimerized bivalent binding agents
06/07/2012US20120142891 Fusion protein systems suitable for high expression of peptides
06/07/2012US20120142890 Biosynthetic Polypeptide Fusion Inhibitors
06/07/2012US20120142593 Factor VIII Variants and Methods of Use
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120142098 Fc receptor-binding polypeptides with modified effector functions
06/07/2012US20120142097 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142015 Gfp fusion proteins and their use
06/07/2012US20120141983 Quantitative Aggregation Sensors
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 295